What researchers published on Mesothelioma
602 papers, newest first.
Showing 40 of 602
Not labelled yetEvolution and distribution of malignant pleural mesothelioma mortality in Spain: 2016-2022.Pulmonology
Not labelled yetOutcomes of Platinum plus /Pemetrexed Rechallenge in Pleural Mesothelioma: The Role of Platinum-Free Interval in a Multicenter Real-World Analysis.JTO clinical and research reports
Not labelled yetMultiomics Analysis of Malignant Pleural Mesothelioma Reveals the Immunological Microenvironment Associated with MTAP Loss and Immunotherapy Outcomes.Clinical cancer research : an official journal of the American Association for Cancer Research
Not labelled yet[Current State of the Asbestos Outpatient Clinic and an Evaluation of Asbestos Bodies].Kyobu geka. The Japanese journal of thoracic surgery
Case report[Surgical Case of Primary Malignant Pericardial Mesothelioma].Kyobu geka. The Japanese journal of thoracic surgery
Not labelled yetUSP14 promotes malignant pleural mesothelioma progression and suppresses autophagy by stabilizing the YAP1-TEAD4 axis.Molecular biology reports
ReviewCross-lineage mesenchymal transition in mesothelioma.Cancer metastasis reviews
Not labelled yetPrognostic factors after multimodality treatment for pleural mesothelioma.Interdisciplinary cardiovascular and thoracic surgery
Not labelled yetPrognostic associations of PD-L1 expression and BAP1 loss in pleural mesothelioma: a retrospective single-center cohort from Colombia.Frontiers in oncology
Not labelled yetMultimodality imaging in the diagnosis and staging of malignant pleural mesothelioma.BMJ case reports
Not labelled yetAnti-Ma1/Ma2 paraneoplastic neurological syndrome associated with malignant mesothelioma: a case study.BMJ neurology open
Not labelled yetMachine learning, molecular docking, and experimental validation identify shared molecular signatures between idiopathic pulmonary arterial hypertension and malignant pleural mesothelioma: a retrospective study.Frontiers in genetics
Not labelled yetPost-Recurrence Treatment Patterns and Outcomes After Curative-Intent Multimodality Strategy in Patients with Pleural Mesothelioma: A Retrospective Cohort Study.Journal of clinical medicine
Not labelled yetPrognostic Significance of B7-H3, TROP2, and p16 Expression in Pleural Mesothelioma: Clinicopathological Correlations and Survival Outcomes.Journal of clinical medicine
Not labelled yetTreatment-specific Association of H&E-based Stromal Tumor-infiltrating Lymphocytes With Survival in Pleural Mesothelioma Treated With Ipilimumab/Nivolumab or Chemotherapy.Anticancer research
ReviewMTAP Loss and Pleural Mesothelioma (PM): Current Treatment Strategies and Emerging Therapeutic Approaches.Cancers
Not labelled yetCorrection: Strategic selection of MDM2 inhibitors enhances the efficacy of FAK inhibition in mesothelioma based on TP53 genotype.PloS one
Not labelled yetIntegrative Bioinformatics and Machine Learning Approaches for Biomarker and Pathway Discovery in Malignant Pleural Mesothelioma.Cancer reports (Hoboken, N.J.)
Not labelled yetHMGB1 directly activates BAP1 transcription to sustain tumor growth in mesothelioma.Cell death and differentiation
ReviewReprogramming the tumor microenvironment in mesothelioma: from immune suppression to therapeutic opportunity.Frontiers in immunology
Case reportUltrasonic manifestations of diffuse pericardial mesothelioma masquerading as pericardial effusion: a case report.Frontiers in oncology
Not labelled yetWhen art anticipates disease: asbestos, conceptual painting and mesothelioma.Medical humanities
Not labelled yetRandomised pilot and feasibility study comparing video-assisted thoracoscopic partial pleurectomy-decortication with indwelling pleural catheter for trapped lung in pleural mesothelioma.Thorax
Not labelled yetBeyond the pleura: National trends in mesothelioma mortality by anatomical site in Spain, 1999-2024.Cancer epidemiology
Not labelled yetHexokinase II as a Potential Target of Apigenin Through the Induction of Apoptosis and Necroptosis in Malignant Mesothelioma.Nutrients
Not labelled yetAwareness of Partial Loss is Essential in Interpreting Merlin Immunohistochemistry When Diagnosing Pleural Mesothelioma.Pathology international
Case reportNephrotic Syndrome During Ipilimumab Plus Nivolumab Therapy for Sarcomatoid Malignant Pleural Mesothelioma: A Case Report of Nivolumab Rechallenge Without Recurrence of Nephrotic Syndrome.Cureus
Case reportPleural Mesothelioma With Unusual Squamous Differentiation: A Clinicopathological Case Report With Molecular Insights From Whole-Exome Sequencing.Pathology international
Not labelled yetCorrection: Hypomethylation reduced the aggressive potential of human malignant mesothelioma cells.Oncogene
Not labelled yetFANCD2 knockdown suppresses malignant phenotypes and is associated with caspase/PARP-mediated apoptosis in NCI-H2052 pleural mesothelioma cells.Frontiers in genetics
Case reportCase Report: Observational use of mycophenolate mofetil in probable steroid-unresponsive immune checkpoint inhibitor-associated transverse myelitis.Frontiers in immunology
Not labelled yetASO Author Reflections: Clinical-Pathological Parameters Remain Key Prognostic Factors in Patients with Peritoneal Mesothelioma following Cytoreductive Surgery and Intraperitoneal Chemotherapy.Annals of surgical oncology
Not labelled yetEpidemiology, exposure patterns and survival of malignant mesothelioma in Apulia, Italy (1993-2025): a population-based retrospective registry study.BMJ open
Not labelled yetPrimum Non Nocere: Surgery and Adjuvant Therapy for Pleural Mesothelioma.The Annals of thoracic surgery
Case reportMalignant mesothelioma of the tunica vaginalis testis: A case report.Oncology letters
Not labelled yetEnvironmental Asbestos Exposure as a Possible Pathway to Early-Onset Pleural Mesothelioma: A Case From Afghanistan and Pakistan to London.Respirology case reports
Case reportPrimary malignant mesothelioma of the tunica vaginalis presenting as hydrocele: imaging pitfalls.BMJ case reports
Not labelled yetExperimental assessment of computationally nominated small molecules targeting the YAP-TEAD interface in Hippo pathway-altered mesothelioma cell models.Frontiers in oncology
ReviewImmunotherapy for Pleural Mesothelioma.Journal of the National Comprehensive Cancer Network : JNCCN
Not labelled yetVISTA drives tumour-intrinsic proliferation in mesothelioma cells.British journal of cancer